Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Drake

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 25, 2018
Tumor grade and sex should influence the utilization of portal lymphadenectomy for early stage intrahepatic cholangiocarcinomaSean P Martin, Samantha Ruff, Laurence P Diggs, et al.
American Journal of Obstetrics and Gynecology|August 26, 2020
Computational medicine, present and the future: obstetrics and gynecology perspectiveRadek Bukowski, Karl Schulz, Kelly Gaither, et al.
Annals of Surgical Oncology|January 12, 2020
Elevated Serum α-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative ResectionJames D McDonald, Shreya Gupta, Mackenzie L Shindorf, et al.
Annals of Surgical Oncology|March 22, 2019
Laparoscopic Approach to Intrahepatic Cholangiocarcinoma is Associated with an Exacerbation of Inadequate Nodal StagingSean P Martin, Justin Drake, Michael M Wach, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 22, 2019
Resection and chemotherapy is the optimal treatment approach for patients with clinically node positive intrahepatic cholangiocarcinomaSean P Martin, Justin Drake, Michael M Wach, et al.
Oncogene|October 2, 2019
Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1Yuan Xu, Deborah R Surman, Laurence Diggs, et al.
Cell|March 25, 2021
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasisSabina Kaczanowska, Daniel W Beury, Vishaka Gopalan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 25, 2018
Tumor grade and sex should influence the utilization of portal lymphadenectomy for early stage intrahepatic cholangiocarcinomaSean P Martin, Samantha Ruff, Laurence P Diggs, et al.
American Journal of Obstetrics and Gynecology|August 26, 2020
Computational medicine, present and the future: obstetrics and gynecology perspectiveRadek Bukowski, Karl Schulz, Kelly Gaither, et al.
Annals of Surgical Oncology|January 12, 2020
Elevated Serum α-Fetoprotein is Associated with Abbreviated Survival for Patients with Fibrolamellar Hepatocellular Carcinoma Who Undergo a Curative ResectionJames D McDonald, Shreya Gupta, Mackenzie L Shindorf, et al.
Annals of Surgical Oncology|March 22, 2019
Laparoscopic Approach to Intrahepatic Cholangiocarcinoma is Associated with an Exacerbation of Inadequate Nodal StagingSean P Martin, Justin Drake, Michael M Wach, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 22, 2019
Resection and chemotherapy is the optimal treatment approach for patients with clinically node positive intrahepatic cholangiocarcinomaSean P Martin, Justin Drake, Michael M Wach, et al.
Oncogene|October 2, 2019
Bile acid-induced "Minority MOMP" promotes esophageal carcinogenesis while maintaining apoptotic resistance via Mcl-1Yuan Xu, Deborah R Surman, Laurence Diggs, et al.
Cell|March 25, 2021
Genetically engineered myeloid cells rebalance the core immune suppression program in metastasisSabina Kaczanowska, Daniel W Beury, Vishaka Gopalan, et al.
Pageof 2